ST. LOUIS , MO | November 16, 2021
The 2021 “State of Lung Cancer” report shows that Missouri ranks fourth in the nation for receiving lung cancer treatment after being diagnosed. Only North Dakota, Rhode Island and Massachusetts have a higher percentage of lung cancer cases getting treatment.
The American Lung Association’s 4th annual report, released today, highlights how the toll of lung cancer varies by state and examines key indicators throughout the U.S. including: new cases, survival, early diagnosis, surgical treatment, lack of treatment and screening rates. This is the second year that the “State of Lung Cancer” report explores the lung cancer burden among racial and ethnic minority groups at the national and state levels.
The report found that Missouri ranked:
- 4 in the nation (top) for lack of treatment at 15.9%. Nationally, 21.1% of cases receive no treatment.
- 45 in the nation (below average) for new lung cancer cases at 71 per 100,000 people. The national rate of new lung cancer cases is 57.7 per 100,000 people.
- 32 in the nation (below average) for survival at 21.6%. The national average of people alive five years after a lung cancer diagnosis is 23.7%.
- 21 in the nation (average) for early diagnosis at 24.8%. Nationally, only 24.5% of cases are diagnosed at an early stage when the five-year survival rate is much higher.
- 18 in the nation (average) for lung cancer screening at 7.5%. Lung cancer screening with annual low-dose CT scans for those at high risk can reduce the lung cancer death rate by up to 20%. Nationally, only 5.7% of those at high risk were screened.
- 35 in the nation (below average) for surgery at 18%. Lung cancer can often be treated with surgery if it is diagnosed at an early stage and has not spread. Nationally, 20.7% of cases underwent surgery.
- In Missouri, Black Americans are less likely to receive surgical treatment than white Americans (13.6% vs. 18.4%, respectively).
The report shows nationally that people of color who are diagnosed with lung cancer face worse outcomes compared to white Americans. It reveals that the lung cancer five-year survival rate increased 14.5% nationally to 23.7% yet remains significantly lower among communities of color. In fact, while the national lung cancer survival rate increased, it remains at only 20% for communities of color and 18% for Black Americans.
“While we celebrate that more Americans are surviving lung cancer, too many people are being left behind, and the disease remains the leading cause of cancer deaths,” said Plesetta Clayton, division director of health promotions at the Lung Association. “Much more can and must be done in Missouri to prevent the disease and support those facing the disease.”
While the “State of Lung Cancer” report findings show significant work needs to be done, there is hope. In March of 2021, the United States Preventive Services Task Force expanded its recommendation for screening to include a larger age range and more current or former smokers. This dramatically increased the number of women and Black Americans who are eligible for lung cancer screening.
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, which has a 4-star rating from Charity Navigator and is a Gold-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.
A Breath of Fresh Air in Your Inbox
Want updates on the latest lung health news, including COVID-19, research, inspiring stories and health information?
Join the 700,000+ people getting our email updates!
A Breath of Fresh Air in Your Inbox
You will now receive email updates from the American Lung Association.